InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: thenewmixer post# 39139

Tuesday, 08/04/2015 11:01:57 AM

Tuesday, August 04, 2015 11:01:57 AM

Post# of 144814
What failed trials? All trials associated with PMCB have been successful. From where did you hear about failed trials?

Here is what we know so far from the recent trials with TD2...

"Preliminary data analysis suggests that treatment with PharmaCyte Biotech’s live-cell encapsulation technology, Cell-in-a-Box(R) plus ifosfamide, produces a significant survival advantage as compared to non-treated control animals. PharmaCyte Biotech’s treatment appears to be at least as good as cisplatin, the current standard of care for ovarian cancer. However, when the encapsulated cells plus ifosfamide were used in conjunction with cisplatin, the survival rate was greatly enhanced."

http://www.pharmacytebiotech.com/nuvilex-announces-preliminary-data-preclinical-study-effects-pancreatic-cancer-treatment-ascites-fluid-formation/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News